Andere Kunden interessierten sich auch für
![CD34, VEGF, VEGFR-1 as angiogenesis markers in Non- Hodgkin¿s Lymphoma]( "CD34, VEGF, VEGFR-1 as angiogenesis markers in Non- Hodgkin¿s Lymphoma")
CD34, VEGF, VEGFR-1 as angiogenesis markers in Non- Hodgkin¿s Lymphoma29,99 €![Canine Melanoma: immunohistochemical evaluation of CD117/KIT receptor expression]( "Canine Melanoma: immunohistochemical evaluation of CD117/KIT receptor expression")
Canine Melanoma: immunohistochemical evaluation of CD117/KIT receptor expression47,95 €![The immune microenvironment of bladder cancer]( "The immune microenvironment of bladder cancer")
The immune microenvironment of bladder cancer29,99 €![GASTROINTESTINAL STROMAL TUMORS]( "GASTROINTESTINAL STROMAL TUMORS")
GASTROINTESTINAL STROMAL TUMORS39,99 €![Endometrioid carcinomas of the endometrium]( "Endometrioid carcinomas of the endometrium")
Endometrioid carcinomas of the endometrium29,99 €![Inflammatory Markers and the Prognosis of Severe Exacerbation of COPD]( "Inflammatory Markers and the Prognosis of Severe Exacerbation of COPD")
Inflammatory Markers and the Prognosis of Severe Exacerbation of COPD53,99 €![CyclinD1 Expression among Sudanese Patients with Colorectal Cancer]( "CyclinD1 Expression among Sudanese Patients with Colorectal Cancer")
CyclinD1 Expression among Sudanese Patients with Colorectal Cancer29,99 €
Our research talks about different roles of immunohistochemical markers that have diverse functions in cancer progression, diagnosis and patient prognosis. We tried to clarify roles of different markers in cancers of many organs, trying to help to find recent distinctive diagnostic and therapeutic modalities to improve cancer diagnosis and patient prognosis. So we study different types of cancer on a particular number of patients.